share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin

Arcutis Biotherapeutics | 4：持股變動聲明-高管 Watanabe Todd Franklin
美股SEC公告 ·  2024/11/06 05:51

牛牛AI助理已提取核心訊息

Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, completed a sale of 13,871 shares of common stock on November 4, 2024. The transaction was executed at a price of $8.6842 per share, resulting in a total sale value of approximately $120,458.54. Following the sale, Watanabe directly holds 832,392 shares of the company. Additionally, Watanabe has indirect ownership of 231,140 shares through various trusts and an LLC. The sale took place in the open market and was part of a planned disposition of shares.
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, completed a sale of 13,871 shares of common stock on November 4, 2024. The transaction was executed at a price of $8.6842 per share, resulting in a total sale value of approximately $120,458.54. Following the sale, Watanabe directly holds 832,392 shares of the company. Additionally, Watanabe has indirect ownership of 231,140 shares through various trusts and an LLC. The sale took place in the open market and was part of a planned disposition of shares.
Todd Franklin Watanabe，與arcutis biotherapeutics有關，於2024年11月4日完成了對13,871股普通股的出售。該交易以每股8.6842美元的價格執行，總銷售價值約爲$120,458.54。銷售後，Watanabe直接持有公司832,392股。此外，Watanabe通過各種信託和有限責任公司間接擁有231,140股。該銷售是在公開市場上進行的，是計劃中的股份處置的一部分。
Todd Franklin Watanabe，與arcutis biotherapeutics有關，於2024年11月4日完成了對13,871股普通股的出售。該交易以每股8.6842美元的價格執行，總銷售價值約爲$120,458.54。銷售後，Watanabe直接持有公司832,392股。此外，Watanabe通過各種信託和有限責任公司間接擁有231,140股。該銷售是在公開市場上進行的，是計劃中的股份處置的一部分。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間